Saad Mark E sold AXSM
December 31, 2025 · Form 4 insider transaction
Saad Mark E sold 6,231 shares of Axsome Therapeutics, Inc. at $165.18 per share, a transaction worth $1.03M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,231
Price
$165.18
Total value
$1.03M
InsiderSaad Mark E
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 31, 2025
Filing dateJanuary 2, 2026
Shares owned after10,002
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such transaction was pursuant to a pre-approved 10b5-1 plan.; Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.; Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09.